Skip to main content

Biologics

Biologics

TargetSite Therapeutics

A new version of CAR with improved antigen sensitivity

Engineering Beta Cells for Resistance to Immune Attack and Reversal of Diabetes

Epiregulin Inhibition to Treat Scleroderma Skin and Lung Fibrosis

ReImmune: A Disposable Bed-Side Device for T cell Immunotherapy without Genetic Engineering

Targeting Profibrotic Macrophages Using Mir-33 Inhibitors, a Novel Therapeutic Approach for Pulmonary Fibrosis

First-in-Class Humanized Anti-DKK2 for Colorectal Cancer

Reversing Axonal Spheroids and Conduction Defects in Alzheimer’s Disease

Novel Therapeutic for the Treatment of Renal Cell Carcinoma

Subscribe to Biologics